Kit Level Monitoring
The clinical supply chain is changing significantly in the wake of advancing pharmaceutical therapies geared towards personalized health care and user-specific gene therapies. Since more manufacturers opt to reach the patient directly and avoid the classical supply chain modalities with its numerous intermediaries, the traditional approach to data collection is proving ineffective and uneconomical. As a result, kit level monitoring is gaining momentum as the most efficient data collection and product monitoring technique.
While product monitoring has good production and distribution guidelines before it reaches the clinical site, there are no guidelines for distribution beyond the clinical site. However, recent innovations in clinical trial monitoring have pushed regulatory authorities to consider, with utmost keenness product quality monitoring during the last mile. As a result, kit level monitoring is becoming the best technique since it offers reliability, continuous remote monitoring, and easy data access. Additionally, it is compact and economical.